Syndax Pharmaceuticals Inc Contracts & Agreements

154 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Employment Agreement, dated March 18, 2024, by and between the Company and Steven Closter
Employment Agreements
Syndax Pharmaceuticals Inc
2024
Description of Capital Stock
Stock Agreements
Syndax Pharmaceuticals Inc
2024
Syndax Pharmaceuticals, Inc. 2023 Inducement Plan
Syndax Pharmaceuticals Inc
2024
Amendment to Amended and Restated Executive Employment by and between the Company and Michael A. Metzger, dated as of February 26, 2024
Employment Agreements
Syndax Pharmaceuticals Inc
2024
Amended and Restated Executive Employment Agreement by and between the Company and Luke J. Albrecht, dated as of April 27, 2020
Employment Agreements
Syndax Pharmaceuticals Inc
2024
Amendment to Amended and Restated Executive Employment by and between the Company and Luke J. Albrecht, dated as of February 26, 2024
Employment Agreements
Syndax Pharmaceuticals Inc
2024
Amendment to Executive Employment by and between the Company and Catherine Madigan, M.D., dated as of February 26, 2024
Employment Agreements
Syndax Pharmaceuticals Inc
2024
Amendment to Executive Employment by and between the Company and Keith A. Goldan, dated as of February 26, 2024
Employment Agreements
Syndax Pharmaceuticals Inc
2024
Amendment to Executive Employment by and between the Company and Neil Gallagher, M.D., Ph.D., dated as of February 26, 2024
Employment Agreements
Syndax Pharmaceuticals Inc
2024
Non-employee Director Compensation Policy, as amended, dated as of February 7, 2024
Compensation Agreements
Syndax Pharmaceuticals Inc
2024
Underwriting Agreement, dated December 14, 2023, by and between the Company and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC
Underwriting Agreements
Syndax Pharmaceuticals Inc
2023
Sales Agreement, dated May 26, 2023
Sales Agreements
Syndax Pharmaceuticals Inc
2023
Syndax Pharmaceuticals, Inc. 2023 Inducement Plan
Syndax Pharmaceuticals Inc
Biotechnology
DE
2023
Form of Option Agreement pursuant to the Syndax Pharmaceuticals, Inc. 2023 Inducement Plan
Syndax Pharmaceuticals Inc
Biotechnology
DE
2023
Underwriting Agreement, dated December 6, 2022, by and between the Company and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC
Underwriting Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2022
Employment Agreement, dated December 1, 2022, by and between the Company and Steve Sabus
Employment Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2022
MUTUAL RELEASE AND SETTLEMENT AGREEMENT
Settlement Agreements
Syndax Pharmaceuticals Inc
2022
Employment Agreement, dated June 8, 2022, by and between the Company and Keith A. Goldan
Employment Agreements
Syndax Pharmaceuticals Inc
2022
Executive Employment Agreement by and between the Company and Catherine Madigan, M.D., dated as of March 1, 2022
Employment Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2022
Executive Employment Agreement by and between the Company and Anjali Ganguli, Ph.D., dated as of September 30, 2021
Employment Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2022
Amended and Restated Executive Employment Agreement by and between the Company and Briggs W. Morrison, M.D., dated as of February 2, 2022
Employment Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2022
Amended and Restated Executive Employment Agreement by and between the Company and Michael A. Metzger, dated as of February 2, 2022
Employment Agreements
Syndax Pharmaceuticals Inc
2022
Non-employee Director Compensation Policy, as amended, dated as of February 2, 2022
Compensation Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2022
First Amendment to the Companys Loan and Security Agreement with the several banks and financial institutions or entities from time-to-time party thereto and Hercules Capital,...
Loan Agreements
Syndax Pharmaceuticals Inc
Biotechnology
CA
2022
Amended and Restated Employment Agreement, dated February 2, 2022, by and between the Company and Briggs W. Morrison, M.D
Employment Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2022
Amended and Restated Employment Agreement, dated February 2, 2022, by and between the Company and Michael A. Metzger
Employment Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2022
Underwriting Agreement, dated December 15, 2021, by and among the Company and Goldman Sachs & Co. LLC
Underwriting Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2021
Form of Pre-Funded Warrant (2021)
Warrant Agreements
Syndax Pharmaceuticals Inc
2021
Collaboration and License Agreement by and between the Company and Incyte Corporation, dated as of September 24, 2021
Collaboration Agreements
Syndax Pharmaceuticals Inc
2021
Stock Purchase Agreement by and between the Company and Incyte Corporation, dated as of September 24, 2021
Stock Agreements
Syndax Pharmaceuticals Inc
Biotechnology
DE
2021
Form of Deferred Settlement Stock Unit Agreement under 2015 Omnibus Incentive Plan
Bonus & Incentive Agreements
Syndax Pharmaceuticals Inc
Biotechnology
DE
2021
Underwriting Agreement, dated December 8, 2020, by and among the Company, Goldman Sachs & Co. LLC, Citigroup Global Markets Inc. and Cowen and Company, LLC
Underwriting Agreements
Syndax Pharmaceuticals Inc
2020
Executive Employment Agreement by and between the Company and Daphne Karydas, dated as of July 6, 2020
Employment Agreements
Syndax Pharmaceuticals Inc
2020
Form of Stock Unit Agreement under 2015 Omnibus Incentive Plan
Bonus & Incentive Agreements
Syndax Pharmaceuticals Inc
2020
Amendment No. 12 to Clinical Trial Agreement by and between the Company and ECOG-ACRIN Cancer Research Group, dated May 12, 2020
Syndax Pharmaceuticals Inc
Biotechnology
2020
Loan and Security Agreement dated February 7, 2020 between Syndax Pharmaceuticals, Inc. and Hercules Capital, Inc
Loan Agreements
Syndax Pharmaceuticals Inc
2020
Non-employee Director Compensation Policy, as amended, February 12, 2020
Compensation Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2020
Amended and Restated Executive Employment Agreement by and between the Company and Briggs W. Morrison, M.D., dated as of April 27, 2020
Employment Agreements
Syndax Pharmaceuticals Inc
2020
Amended and Restated Executive Employment Agreement by and between the Company and Michael A. Metzger, dated as of April 27, 2020
Employment Agreements
Syndax Pharmaceuticals Inc
2020
Amended and Restated Executive Employment Agreement by and between the Company and Michael L. Meyers, M.D., Ph.D., dated as of April 27, 2020
Employment Agreements
Syndax Pharmaceuticals Inc
2020
Amended and Restated Executive Employment Agreement by and between the Company and Richard P. Shea, dated as of April 27, 2020
Employment Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2020
Underwriting Agreement, dated April 30, 2020, by and among the Company, Citigroup Global Markets Inc. and Cowen and Company, LLC
Underwriting Agreements
Syndax Pharmaceuticals Inc
2020
Description of Capital Stock
Stock Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2020
Form of Pre-Funded Warrant
Warrant Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2020
Purchase Agreement between the Company and the Purchasers, dated January 30, 2020
Purchase Agreements
Syndax Pharmaceuticals Inc
2020
Amendment No. 11 to Clinical Trial Agreement by and between the Company and ECOG-ACRIN Cancer Research Group, dated July 1, 2019
Syndax Pharmaceuticals Inc
Biotechnology
2019
Amendment No. 1 to License Agreement by and between the Company and UCB Biopharma Sprl, dated as of July 9, 2019
License Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2019
Amendment No. 1 to License Agreement by and between the Company and Vitae Pharmaceuticals, Inc., dated as of January 25, 2019
License Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2019
Form of Series Warrant
Warrant Agreements
Syndax Pharmaceuticals Inc
2019
Form of Pre-Funded Warrant
Warrant Agreements
Syndax Pharmaceuticals Inc
2019
Purchase Agreement between the Company and the Purchasers, dated March 26, 2019
Purchase Agreements
Syndax Pharmaceuticals Inc
2019
Purchase Agreement between the Company and the Purchaser, dated March 28, 2019
Purchase Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2019
Amendment No. 10 to Clinical Trial Agreement by and between the Company and ECOG-ACRIN Cancer Research Group, dated October 15, 2018
Syndax Pharmaceuticals Inc
Biotechnology
2019
Amendment #4 to License, Development and Commercialization Agreement by and between the company and Kyowa Hakko Kirin Co., Ltd., dated May 29, 2018
License Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2018
Form of Warrant Agreement
Warrant Agreements
Syndax Pharmaceuticals Inc
2018
Exchange Agreement between Syndax Pharmaceuticals, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, L.P., dated...
Exchange Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2018
Amendment #3 to License, Development and Commercialization Agreement by and between the company and Kyowa Hakko Kirin Co., Ltd., dated March 27, 2018
License Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2018
Amendment No. 9 to Clinical Trial Agreement by and between the Company and ECOG-ACRIN Cancer Research Group, dated November 22, 2017
Syndax Pharmaceuticals Inc
Biotechnology
2018
License Agreement by and between the Company and Vitae Pharmaceuticals, Inc., dated as of October 13, 2017
License Agreements
Syndax Pharmaceuticals Inc
2018
Purchase Agreement, dated October 17, 2017
Purchase Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2017
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Syndax Pharmaceuticals Inc
2017
AMENDMENT NO. 1 TO CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT (FOR NON-SMALL CELL LUNG CANCER STUDY WITH EXPANSION COHORTS INNON-SMALL CELL LUNG CANCER, MELANOMA, AND...
Collaboration Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2017
3,750,000 Shares SYNDAX PHARMACEUTICALS, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT
Underwriting Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2017
AMENDMENT NO. 7 TO CLINICAL TRIAL AGREEMENT BETWEEN ECOG-ACRINCANCER RESEARCH GROUP AND SYNDAX PHARMACEUTICALS, INC.
Syndax Pharmaceuticals Inc
2017
AMENDMENT #2 TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Syndax Pharmaceuticals Inc
2017
AMENDMENT NO. 8 TO CLINICAL TRIAL AGREEMENT BETWEEN ECOG-ACRINCANCER RESEARCH GROUP AND SYNDAX PHARMACEUTICALS, INC.
Syndax Pharmaceuticals Inc
2017
SIDE AGREEMENT to the License Agreement dated 1st July 2016 between UCB Biopharma Sprl and Syndax Pharmaceuticals, Inc. (License Agreement)
License Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2017
LICENSE AGREEMENT
License Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2016
AMENDMENT NO. 3 TO CLINICAL TRIAL AGREEMENT BETWEEN ECOG-ACRINCANCER RESEARCH GROUP AND SYNDAX PHARMACEUTICALS, INC.
Syndax Pharmaceuticals Inc
2016
AMENDMENT NO. 4 TO CLINICAL TRIAL AGREEMENT E2112 BETWEEN ECOG-ACRINCANCER RESEARCH GROUP AND SYNDAX PHARMACEUTICALS, INC.
Syndax Pharmaceuticals Inc
2016
AMENDMENT NO. 5 TO CLINICAL TRIAL AGREEMENT BETWEEN ECOG-ACRINCANCER RESEARCH GROUP AND SYNDAX PHARMACEUTICALS, INC.
Syndax Pharmaceuticals Inc
Biotechnology
2016
AMENDMENT NO. 6 TO CLINICAL TRIAL AGREEMENT BETWEEN ECOG-ACRINCANCER RESEARCH GROUP AND SYNDAX PHARMACEUTICALS, INC.
Syndax Pharmaceuticals Inc
Biotechnology
2016
AMENDMENT NO. 2 TO CLINICAL TRIAL AGREEMENT E2112 BETWEEN ECOG-ACRIN CANCER RESEARCHGROUP AND SYNDAX PHARMACEUTICALS, INC.
Syndax Pharmaceuticals Inc
Biotechnology
2016
FIRST AMENDMENT
Syndax Pharmaceuticals Inc
Biotechnology
2016
AMENDMENT # 1 TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2016
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2016
CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT
Collaboration Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2016
Shares Syndax Pharmaceuticals, Inc. Common Stock ($0.0001 Par Value) EQUITY UNDERWRITING AGREEMENT
Underwriting Agreements
Syndax Pharmaceuticals Inc
2016
SYNDAX PHARMACEUTICALS, INC. WARRANT CERTIFICATE
Warrant Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
SYNDAX PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS
Investor Rights Agreements
Syndax Pharmaceuticals Inc
Biotechnology
DE
2016
WARRANT AGREEMENT between SYNDAXPHARMACEUTICALS, INC. and BAYER SCHERING PHARMA AG Dated as of March 26, 2007 Table of Contents
Warrant Agreements
Syndax Pharmaceuticals Inc
2016
SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
2016
AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
2016
AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
2016
AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
2016
AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN NOTICE OF STOCK OPTION GRANT
Stock Agreements
Syndax Pharmaceuticals Inc
Biotechnology
CA
2016
SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN NOTICE OF STOCK OPTION GRANT
Stock Agreements
Syndax Pharmaceuticals Inc
2016
SYNDAX PHARMACEUTICALS, INC. 2015 OMNIBUS INCENTIVE PLAN TABLE OF CONTENTS
Bonus & Incentive Agreements
Syndax Pharmaceuticals Inc
2016
SYNDAX PHARMACEUTICALS, INC. 2015 OMNIBUS INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Syndax Pharmaceuticals Inc
Biotechnology
DE
2016
SYNDAX PHARMACEUTICALS, INC. 2015 OMNIBUS INCENTIVE PLAN NON-QUALIFIED OPTION AGREEMENT
Bonus & Incentive Agreements
Syndax Pharmaceuticals Inc
2016
SYNDAX PHARMACEUTICALS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
2016
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Syndax Pharmaceuticals Inc
2016
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Syndax Pharmaceuticals Inc
2016
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Syndax Pharmaceuticals Inc
2016
Exhibit A
Syndax Pharmaceuticals Inc
Biotechnology
DE
2016
GENERAL RELEASE AND POST-SEPARATION CONSULTING AGREEMENT
Consulting Agreements
Syndax Pharmaceuticals Inc
Biotechnology
MA
2016
INDEMNIFICATION AGREEMENT
Indemnification Agreements
Syndax Pharmaceuticals Inc
2016
LICENSE,DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
Syndax Pharmaceuticals Inc
2016
FIRST AMENDMENTTO THE LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
SECOND AMENDMENT TO THE LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
THIRD AMENDMENTTO THE LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Syndax Pharmaceuticals Inc
2016
CLINICAL TRIALAGREEMENT
Syndax Pharmaceuticals Inc
Biotechnology
PA
2016
AMENDMENT NO. 1TO CLINICAL TRIAL AGREEMENT BETWEEN ECOG-ACRINCANCER RESEARCH GROUP AND SYNDAX PHARMACEUTICALS, INC.
Syndax Pharmaceuticals Inc
2016
SOLAR CAPITAL LOAN ANDSECURITY AGREEMENT
Loan Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2016
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Syndax Pharmaceuticals Inc
2016
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Syndax Pharmaceuticals Inc
2016
CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT (FOR NON-SMALL CELL LUNG CANCER STUDY WITH EXPANSION COHORTS IN NON-SMALL CELL LUNG CANCER AND MELANOMA)
Collaboration Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
LICENSE,DEVELOPMENT AND COMMERCIALIZATION AGREEMENT Dated December 19, 2014 by and between SYNDAXPHARMACEUTICALS, INC. and KYOWA HAKKO KIRIN CO., LTD.
Syndax Pharmaceuticals Inc
Biotechnology
NY
2016
[signature pages follow] Syndax Pharmaceuticals,Inc., 400 Totten Pond Road, Suite 110, Waltham, MA 02451 Telephone: 781 ###-###-#### Fax: 781 ###-###-####
Syndax Pharmaceuticals Inc
2016
COMBINATION STUDY COLLABORATION AGREEMENT BETWEEN GENENTECH, INC. AND SYNDAX PHARMACEUTICALS, INC. TABLE OF CONTENTS
Collaboration Agreements
Syndax Pharmaceuticals Inc
2016
CONVERTIBLE UNSECURED PROMISSORY NOTE
Note Agreements
Syndax Pharmaceuticals Inc
Biotechnology
DE
2014
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Syndax Pharmaceuticals Inc
2014
SYNDAX PHARMACEUTICALS, INC. CONVERTIBLE NOTE PURCHASE AGREEMENT
Note Agreements
Syndax Pharmaceuticals Inc
2014
SOLAR CAPITAL LOAN ANDSECURITY AGREEMENT
Loan Agreements
Syndax Pharmaceuticals Inc
2014
SyndaxPharmaceuticals, Inc. Common Stock ($0.0001 Par Value) EQUITYUNDERWRITING AGREEMENT
Stock Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2014
LICENSE,DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
Syndax Pharmaceuticals Inc
Biotechnology
NY
2014
TABLE OF CONTENTS Section 1 Definitions Section 2 Grant and Reservation of Rights Section 3 Economic Consideration Section 4 Sublicensing Section 5 U.S. Government Rights Section...
Termination Agreements
Syndax Pharmaceuticals Inc
Biotechnology
CO
2014
SYNDAX PHARMACEUTICALS, INC. WARRANT CERTIFICATE
Warrant Agreements
Syndax Pharmaceuticals Inc
2014
SYNDAXPHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS
Investor Rights Agreements
Syndax Pharmaceuticals Inc
2014
WARRANT AGREEMENT between SYNDAXPHARMACEUTICALS, INC. and BAYER SCHERING PHARMA AG Dated as of March 26, 2007 Table of Contents
Warrant Agreements
Syndax Pharmaceuticals Inc
Biotechnology
DE
2014
SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
Biotechnology
DE
2014
AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
2014
AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
2014
AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2014
SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN NOTICE OF STOCK OPTION GRANT
Stock Agreements
Syndax Pharmaceuticals Inc
Biotechnology
CA
2014
SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN NOTICE OF STOCK OPTION GRANT
Stock Agreements
Syndax Pharmaceuticals Inc
Biotechnology
CA
2014
SYNDAX PHARMACEUTICALS, INC. 2013 OMNIBUS INCENTIVE PLAN TABLE OF CONTENTS
Bonus & Incentive Agreements
Syndax Pharmaceuticals Inc
2014
SYNDAX PHARMACEUTICALS, INC. 2013 OMNIBUS INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Syndax Pharmaceuticals Inc
Biotechnology
DE
2014
SYNDAX PHARMACEUTICALS, INC. 2013 OMNIBUS INCENTIVE PLAN NON-QUALIFIED OPTION AGREEMENT
Bonus & Incentive Agreements
Syndax Pharmaceuticals Inc
2014
SYNDAX PHARMACEUTICALS, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2014
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Syndax Pharmaceuticals Inc
Biotechnology
DE
2014
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Syndax Pharmaceuticals Inc
2014
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Syndax Pharmaceuticals Inc
Biotechnology
DE
2014
INDEMNIFICATION AGREEMENT
Indemnification Agreements
Syndax Pharmaceuticals Inc
Biotechnology
DE
2014
LICENSE,DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
Syndax Pharmaceuticals Inc
2014
FIRST AMENDMENTTO THE LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Syndax Pharmaceuticals Inc
2014
SECOND AMENDMENT TO THE LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2014
THIRD AMENDMENTTO THE LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Syndax Pharmaceuticals Inc
2014
TABLE OF CONTENTS Section 1 Definitions Section 2 Grant and Reservation of Rights Section 3 Economic Consideration Section 4 Sublicensing Section 5 U.S. Government Rights Section...
Termination Agreements
Syndax Pharmaceuticals Inc
2014
LOAN AND SECURITY AGREEMENT
Loan Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2014
CONSENT AND AMENDMENT AGREEMENT
Syndax Pharmaceuticals Inc
Biotechnology
DE
2014
CONSENT AND AMENDMENT AGREEMENT
Syndax Pharmaceuticals Inc
2014
CONSENT AND AMENDMENT AGREEMENT
Syndax Pharmaceuticals Inc
Biotechnology
DE
2014
CONSENT AND AMENDMENT AGREEMENT
Syndax Pharmaceuticals Inc
Biotechnology
DE
2014
CONSENT AND AMENDMENT AGREEMENT
Syndax Pharmaceuticals Inc
Biotechnology
DE
2014
CONSENT AND AMENDMENT AGREEMENT
Syndax Pharmaceuticals Inc
2014
CONSENT AND AMENDMENT AGREEMENT
Syndax Pharmaceuticals Inc
2014
CONSENT AND AMENDMENT AGREEMENT
Syndax Pharmaceuticals Inc
Biotechnology
DE
2014
CONSENTAND AMENDMENT AGREEMENT
Syndax Pharmaceuticals Inc
2014
CLINICAL TRIALAGREEMENT
Syndax Pharmaceuticals Inc
Biotechnology
PA
2014